文献
J-GLOBAL ID:201802281250736199
整理番号:18A0974278
標準治療に抵抗性の進行固形腫瘍を有するPIK3CA増幅/突然変異および/またはPTEN損失患者におけるエベロリムスの前向き第II相試験【JST・京大機械翻訳】
Prospective phase II trial of everolimus in PIK3CA amplification/mutation and/or PTEN loss patients with advanced solid tumors refractory to standard therapy
著者 (7件):
Kim Seung Tae
(Department of Medicine, Division of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea)
,
Lee Jeeyun
(Department of Medicine, Division of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea)
,
Park Se Hoon
(Department of Medicine, Division of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea)
,
Park Joon Oh
(Department of Medicine, Division of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea)
,
Park Young Suk
(Department of Medicine, Division of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea)
,
Kang Won Ki
(Department of Medicine, Division of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea)
,
Lim Ho Yeong
(Department of Medicine, Division of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea)
資料名:
BMC Cancer (Web)
(BMC Cancer (Web))
巻:
17
号:
1
ページ:
211
発行年:
2017年
JST資料番号:
U7305A
ISSN:
1471-2407
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
イギリス (GBR)
言語:
英語 (EN)